MedPath

Sequential Medicine Ltd.

🇬🇹Guatemala
Ownership
Private
Employees
-
Market Cap
-
Website

SM-1 vs. an Active Comparator in A Model of Transient Insomnia

Phase 2
Not yet recruiting
Conditions
Transient Insomnia
Interventions
Drug: Active Comparator
First Posted Date
2020-05-20
Last Posted Date
2020-05-20
Lead Sponsor
Sequential Medicine Ltd
Target Recruit Count
14
Registration Number
NCT04396327
Locations
🇺🇸

Clinilabs Drug Development Corporation, New York, New York, United States

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

Phase 3
Withdrawn
Conditions
Transient Insomnia
Interventions
Drug: Placebo
First Posted Date
2017-11-09
Last Posted Date
2024-04-17
Lead Sponsor
Sequential Medicine Ltd
Registration Number
NCT03338764

SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.

Phase 3
Completed
Conditions
Transient Insomnia
Interventions
Drug: D+Z
Drug: D+L
Drug: Placebo
First Posted Date
2017-11-06
Last Posted Date
2019-06-05
Lead Sponsor
Sequential Medicine Ltd
Target Recruit Count
85
Registration Number
NCT03331042
Locations
🇺🇸

Clinilabs, Inc., New York, New York, United States

🇺🇸

NeuroTrials Research, Inc., Atlanta, Georgia, United States

Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia

Phase 2
Completed
Conditions
Short-term Insomnia
Interventions
Drug: Comparator
Drug: Placebo
First Posted Date
2016-02-02
Last Posted Date
2018-03-06
Lead Sponsor
Sequential Medicine Ltd
Target Recruit Count
39
Registration Number
NCT02671760
© Copyright 2025. All Rights Reserved by MedPath